Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts

Dec. 22, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

AEterna's psoriasis agent moves to phase I/II in Canada

Dec. 18, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Dec. 18, 1997

First U.S. trials of Zemaphyte to begin

Dec. 17, 1997

Once-daily tacalcitol vs. twice-daily calcipotriol for chronic plaque psoriasis

Dec. 17, 1997

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...